- Home
- PSFE vs MPLT Comparison
PSFE vs MPLT Comparison
Compare PSFE & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSFE
- MPLT
- Stock Information
- Founded
- PSFE 1996
- MPLT 2018
- Country
- PSFE United Kingdom
- MPLT United States
- Employees
- PSFE N/A
- MPLT N/A
- Industry
- PSFE Business Services
- MPLT Biotechnology: Pharmaceutical Preparations
- Sector
- PSFE Consumer Discretionary
- MPLT Health Care
- Exchange
- PSFE Nasdaq
- MPLT Nasdaq
- Market Cap
- PSFE 599.1M
- MPLT 700.6M
- IPO Year
- PSFE N/A
- MPLT 2025
- Fundamental
- Price
- PSFE $7.38
- MPLT $14.00
- Analyst Decision
- PSFE Sell
- MPLT
- Analyst Count
- PSFE 4
- MPLT 0
- Target Price
- PSFE $17.38
- MPLT N/A
- AVG Volume (30 Days)
- PSFE 427.8K
- MPLT 527.9K
- Earning Date
- PSFE 11-13-2025
- MPLT 11-28-2025
- Dividend Yield
- PSFE N/A
- MPLT N/A
- EPS Growth
- PSFE N/A
- MPLT N/A
- EPS
- PSFE N/A
- MPLT N/A
- Revenue
- PSFE $1,683,103,000.00
- MPLT N/A
- Revenue This Year
- PSFE $3.24
- MPLT N/A
- Revenue Next Year
- PSFE $7.10
- MPLT N/A
- P/E Ratio
- PSFE N/A
- MPLT N/A
- Revenue Growth
- PSFE N/A
- MPLT N/A
- 52 Week Low
- PSFE $7.29
- MPLT $13.33
- 52 Week High
- PSFE $24.11
- MPLT $20.86
- Technical
- Relative Strength Index (RSI)
- PSFE 18.47
- MPLT N/A
- Support Level
- PSFE $9.95
- MPLT N/A
- Resistance Level
- PSFE $10.81
- MPLT N/A
- Average True Range (ATR)
- PSFE 0.51
- MPLT 0.00
- MACD
- PSFE -0.24
- MPLT 0.00
- Stochastic Oscillator
- PSFE 0.18
- MPLT 0.00
About PSFE Paysafe Limited
Paysafe Ltd is an integrated payments platform. Its core purpose is to enable businesses and consumers to connect and transact seamlessly through capabilities in payment processing, digital wallet, and online cash solutions. The company provides payment solutions through three primary lines of business: Integrated Processing, Digital Wallet and eCash Solutions. It derives a majority of revenue from the USA followed by Germany, the UK, and all other countries.
About MPLT MapLight Therapeutics Inc. Common Stock
MapLight Therapeutics Inc is a biopharmaceutical company. The company is focused on improving the lives of patients suffering from debilitating central nervous system, or CNS, disorders. The company is engaged in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The product candidates of the company include ML-007C-MA, ML-004, ML-021, ML-009, and other pipeline products.